MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

July 3, 2025 — A new treatment has received a quick federal nod for a common blood cancer, which could affect more than 36,000 people and result in around 12,000 deaths in the U.S. this year alone.

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

Alyssa Tapley, 16, thought she was going to die of leukaemia before receiving the treatment A therapy that would once have ...